Be in the know. 17 key reads for Wednesday…

  1. Trial Site Operation in San Antonio Reports Positive Momentum for Regeneron Monoclonal Antibody REGN-COV-2 (TrialSiteNews)
  2. J&J’s COVID vaccine enters Phase 3 trial; first to test single-shot regimen (Fox Business)
  3. Powell and Mnuchin Tell Congress: Send More Fiscal Stimulus to Stabilize Recovery (Barron’s)
  4. House Passes Spending Bill to Fund Government Through Dec. 11 (Barron’s)
  5. Podcast: U.S. Crude Oil Exports Rebound to 3 Million Barrels a Day (Barron’s)
  6. As Home Sales Reach Highest Level Since 2006, Luxury Sales Boom (Barron’s)
  7. United Wholesale Mortgage to Go Public Via Merger With Gores SPAC (Wall Street Journal)
  8. The tech-heavy Nasdaq could plunge another 12% from current levels as a key support level is tested, says Morgan Stanley’s investment chief (Business Insider)
  9. Tesla’s stock skids 6% as promised ‘Battery Day’ innovations don’t look like they will be here soon (MarketWatch)
  10. Fujifilm to Seek Approval for Covid Drug After Trial Results (Bloomberg)
  11. 2021 Porsche Panamera Turbo S can hit 196 mph with stunning, immediate power (USA Today)
  12. House Democrats push to renew efforts for second round of $1,200 stimulus checks (CNBC)
  13. Mortgage demand from homebuyers now up 25% from a year ago (CNBC)
  14. U.S. Home Sales Extended Powerful Rebound Into August (Wall Street Journal)
  15. New York City Council Introduces Bills to Aid Restaurants in Coronavirus Recovery (Wall Street Journal)
  16. How a Fortunate Few Airlines Profit in a Pandemic: Lots of Cargo (Wall Street Journal)
  17. Palantir Says 2020 Growth To Exceed 42%, As It Prepares To Go Public Next Week (Benzinga)